Home/Filings/4/0001404644-24-000113
4//SEC Filing

Cvijic Christine Mikail 4

Accession 0001404644-24-000113

CIK 0001404644other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 9:29 PM ET

Size

5.5 KB

Accession

0001404644-24-000113

Insider Transaction Report

Form 4
Period: 2024-11-22
Cvijic Christine Mikail
President and CFO
Transactions
  • Purchase

    Common Stock

    2024-11-22$20.48/sh+24,000$491,40076,844 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.33 to $20.92, inclusive. The reporting person undertakes to provide to Neurogene Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]Includes 24,000 shares held jointly by the reporting person and her spouse, David Cvijic.

Issuer

Neurogene Inc.

CIK 0001404644

Entity typeother

Related Parties

1
  • filerCIK 0001543663

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 9:29 PM ET
Size
5.5 KB